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ABSTRACT
Shipping companies were surveyed to evaluate the effect of public health measures during the
influenza A (H1N1) pandemic of 2009 on ship and port operations. Of 31 companies that ope-
rated 960 cruise, cargo, and other ships, 32% experienced health-screening measures by port
health authorities. Approximately a quarter of ports (26%) performed screening at embarkation
and 77% of shipping companies changed procedures during the early stage of the pandemic.
Four companies reported outbreaks of pandemic influenza A (H1N1) 2009 on ships, which were
ultimately stopped through infection control practices. Public health measures did not interfere
substantially with port and ship operations with the exception of some port authorities that
delayed embarking and disembarking procedures in a few ships. However, in the shipping com-
panies’ experience, measures were inconsistent between port health authorities. Access to anti-
viral drugs and pandemic vaccine was not provided in all ports. Current guidelines on medical
care, hygiene, and emergency procedures on ships need to address pandemic influenza pre-
paredness in future revisions.
(Int Marit Health 2012; 63, 1: 17–23)
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INTRODUCTION
The risk of disease among passengers and crew
caused by transmission of seasonal influenza virus
on ships is well documented. Attack rates in outbreaks
of acute respiratory disease on ships range from 0.5
to 41% [1–5]. During a 2009 workshop of the Inter-
national Maritime Health Association (IMHA) it was
emphasized that Influenza is one of the most com-
mon health problems experienced in sea travel, for
crew and passengers, with documented potential for
outbreaks, and remains the most important vaccine-
preventable respiratory infection in maritime health
[1]. Two outbreaks on ships during the 2009 pandemic
influenza A (H1N1) were reported. An Italian Navy ship
with 237 crew cruised in the Mediterranean during
May to September 2009. Fifty-two cases of acute res-
piratory infection (ARI) were reported. Of the 211 blood
test results available, 39% tested seropositive for pan-
demic Influenza A (H1N1) [7]. In an outbreak on
a Peruvian Navy ship with 355 crew, an attack rate of
22% for confirmed pandemic Influenza A (H1N1) was
documented during June to July 2009 [8].
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Influenza pandemic planning by the shipping in-
dustry was slow or non-existent during the past de-
cade, and regulations or international recommenda-
tions regarding medical supplies aboard ships did
not specifically address the issue, even those that
had been recently updated [9, 10]. This situation
changed rapidly in April 2009 when the World Health
Organization (WHO) announced the emergence of
the new influenza A (H1N1) virus. Guidelines and
protocols for the prevention, detection, and control
of influenza outbreaks on board ships were prepared
and released by different sources. Table 2 summa-
rizes key recommendations of the WHO, CDC, and
IMHA [11–13]. This report documents the public
health measures taken by the international shipping
community in response to the pandemic influenza A
(H1N1) 2009.
THE SURVEY
Shipping companies were surveyed to evaluate the
effect of infection control measures initiated by them
or port authorities on maritime operations during the
early stages of pandemic influenza A (H1N1) 2009.
STUDY POPULATION
Companies were recruited to participate by the
Lyon office of the WHO through the Cruise Lines In-
ternational Association (CLIA — 25 cruise-line mem-
bers representing > 97% of the cruise capacity mar-
keted in North America) and the International Ship-
ping Federation (ISF — 32 national ship owner
association members). Representatives of the mari-
time industry were asked to respond to a question-
naire concerning their experiences from April 20,
2009 through to July 31, 2009. The survey was part
of a greater multi-sectoral evaluation with four ques-
tionnaires each tailored to a specific sector as de-
scribed elsewhere [14]. Collaborators for the survey
in shipping included subject matter experts from the
World Health Organization, the United States Cen-
ters for Disease Control and Prevention, and the
Hamburg Port Health Centre of the Institute for Oc-
cupational and Maritime Medicine, Germany. The
Cruise Lines International Association and the Inter-
national Shipping Federation provided input for the
development of the survey tool and supported dis-
semination of the questionnaire to the study popula-
tion. The protocol was approved by the WHO and the
US Centers for Disease Control and Prevention.
The cross sectional study targeted the senior
administrative level of shipping companies. Represen-
tatives of the maritime industry who are familiar with
the actions taken by the company and with public
health measures aboard their vessels taken in re-
sponse to the pandemic (H1N1) were prompted to
document the control measures from 20
th
 April 2009
through to 31
st
 July 2009 and to share their impres-
sions of the impact it had. Each company was asked
to complete one questionnaire. If a company opera-
ted both cruise and cargo ships, it was asked to com-
plete a separate questionnaire for each sector.
QUESTIONNAIRE DESIGN AND FUNCTIONALITY
The questionnaire was developed by use of Ado-
be® Acrobat Professional Life Cycle Designer. The
questionnaire in English language included 18 ques-
tions for ship operators. The definitions of public
health measures shown in table 1 were given to the
target audience. The answer design was multiple-
choice and free text. The questionnaire was designed
to allow electronic reporting.
QUESTIONNAIRE ADMINISTRATION,
DATA COLLECTION AND MANAGEMENT
Questionnaires were distributed from the WHO
office in Lyon via the International Shipping Federa-
tion and Cruise Line International Association to the
ship operators as an attachment via email. The ques-
tionnaires were returned to the WHO. The first dead-
line for responses was November 27
th
 2009, to im-
prove response rates; the deadline was later exten-
ded to February 15
th
 2010. Several reminders were
sent out during the study period. Responses were
automatically downloaded into a secure database
maintained by the WHO. Data returned by email or
fax were manually entered into the database. Data
were handled anonymously.
DATA ANALYSIS
Descriptive analysis was conducted in Microsoft
Access and Microsoft Excel. Data were stratified for
cruise-lines and other merchant ships operators.
RESULTS
A total of 31 shipping companies that operated
a total of 960 ships, 820 cargo ships, 29 passenger
ships, and 111 other ships (e.g. tankers, tug boats,
supply ships) responded. Regarding the estimated
world fleet of 53,000 ships with a gross tonnage
above 500 [15], the responders represented appro-
ximately 2% of international sailing vessels. Ninety per
cent (28/31) of the companies were based in Eu-
rope and the North Atlantic region. Of the 31 respon-
ding companies, 4 (13%) (3 of them cruise ship com-
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panies) reported events with on-going transmission
of influenza-like illness (ILI, illness with typical signs
and symptoms similar to seasonal influenza includ-
ing fever, cough, headache, body aches, sore throat,
and others) on vessels.
ON BOARD MEASURES
During the study period, 25/31 (81%) shipping
companies, including all three cruise ship compa-
nies, changed their procedures for the prevention
and control of communicable diseases. Most (25/
31; 81%) shipping companies provided targeted
health information to crew and/or passengers. Sour-
ces of information included the WHO (19/31; 76%),
regional or national public health organizations (19/
/31; 61%), shipping associations (10/31; 32%), and
the International Maritime Organization (IMO) (6/31;
19%). Four companies (13%) reported using the
media as a source of information.
Eight of 31 (26%) shipping companies, including
all 3 participating cruise ship companies, reported
that they implemented embarkation health scree-
ning measures (health declarations and temperature
measurements). Secondary health screening was per-
formed on board by the ships’ medical personnel
or private practitioners; port or local public health
Table 1. Definitions
Embarkation health screening measures Any kind of health screening measures of persons due to pandemic
(H1N1) 2009 implemented during embarkation
Visual inspection Looking for people who appear sick or have signs of illness such as cough
Primary health screening First health screening measure applied collectively to all persons embar-
k ing
Secondary health evaluation Further health evaluation for persons who screened positive in primary
health screening
Influenza-like illness Illness with typical signs and symptoms similar to seasonal influenza in-
cluding fever, cough, headache, body-aches, sore throat, runny nose, and
sometimes vomiting or diarrhoea
Isolation Separation of ill persons from others in such a manner as to prevent the
spread of infection
Antiviral treatment: Treatment with antiviral medications like Oseltamivir or Zanamivir
Monitoring Regular monitoring done by ship’s (medical) staff to catch ill persons in
early state of disease
Self-monitoring Demand to monitor self and report any early sign of illness to ship’s
(medical) staff as soon as possible
Quarantine Restriction of activities and/or separation from others of suspect persons
who are not ill to prevent the possible spread of infection
Close contact Close contact on a ship is considered to be a passenger or crew member
who had been in close proximity and in such association with an infected
person or enclosed environment for such a prolonged period of time to
have had opportunity to acquire the infection, such as: sharing a cabin,
family members, travel group members, crew working in shifts at the
same space and having cared for or had direct contact with respiratory se-
cretions or body fluids of an active influenza-like illness case. In addition,
close contact may be considered to include other fellow travellers that
may have had prolonged close proximity contact with an ill passenger in
a crowded and semi-closed environment on board (e.g. during collective
indoor recreational activities requiring close proximity or regularly having
meals together with the infected person)
Preventive antiviral treatment (prophylaxis) Antiviral medications like Oseltamivir or Zanamivir given to prevent onset
of influenza
Event Event means cases of disease on board with on-going transmission
Free pratique Free pratique means permission for a ship to enter a port, embark or di-
sembark, discharge or load cargo or stores
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departments were not involved in this activity. Five of
the 8 shipping companies, including all 3 participa-
ting cruise ship companies, routinely contacted pub-
lic health authorities when persons screened posi-
tive for ILI.
Of the 31 shipping companies, 19 (61%), includ-
ing all cruise ship companies, did not allow persons
identified with symptoms of ILI to board the ship. If
illness occurred during sea passage, affected per-
sons were isolated in their cabins or in the ships’
medical facilities for 3 to 8 days (median 7 days)
after symptoms started. Antiviral treatment was of-
fered by 8 of 31 (26%) companies. Health measures
targeted towards asymptomatic close contact of per-
sons with ILI were adopted by 16 of 31 (52%) ship-
ping companies, including all 3 cruise ship lines. In
view of the 3 cruise lines that operated 29 ships, on-
going transmission of pandemic influenza was suc-
cessfully prevented and controlled with the control
measures used, including targeted health informa-
Table 2. Comparison of selected measures recommended by organizations
US Centers for Disease Control World Health Organization International Maritime Health
Interim Novel Influenza Interim Interim technical advice Association IMHA Influenza A
Guidance for Cruise Ships during for case management of  (H1N1) Interim Advice
the 2009-10 Influenza season pandemic (H1N1) 2009 on ships
Target audience crew members passengers National IHR Focal Points Maritime Industry
of cruise ships Competent authorities at ports
National public health officials
Ship operators
Port administrators
Other port personnel
Ship crew members
Other port authorities
Stakeholders involved in ship travel.
Consequences of Non-embarkation until at least Non-embarkation recommended –
detection of cases  24 hours after resolution of
of ILI during fever recommended
embarkation
screening
Isolation of crew Isolation in cabin until at least Isolation 7 days after symptom onset Isolation of person with ILI
or passenger with 24 hours after resolution of fever  or until they are free of symptoms for in single room or cohort
ILI on board  24 hours, whichever is longer isolation
Managing of Monitor health for 7 Quarantine for close contacts for up monitor health for 7 days
passengers and days after exposure to 7 days after exposure after possible exposure
crew following People at a higher risk of
exposure to an developing severe or complicated
ill person illness should be closely monitored
for symptoms and antiviral
treatment should be initiated promptly
if symptoms develop
Personal protective Facemasks Facemasks Facemasks
equipment for Gloves Antiseptic hand rub Gloves
caregivers of Hand hygiene following CDC impermeable disposable gloves Alcohol-based disinfectants
persons with ILI infection control guidelines
Stockpiling of Antiviral treatment: either Antivirals: oseltamivir Antiviral drugs, such as
Medication and oseltamivir or zanamivir  and/or zanamivir. Tamiflu or Relenza.
Supplies Sterile viral transport media Intravenous fluids, antibiotics, Digital thermometer,
and sterile swabs to collect  antipyretics (paracetamol or facemasks, disinfectants,
nasopharyngeal and nasal acetaminophen), oral rehydration gloves
specimens salts, oxygen, gloves, facemasks, Influenza rapid test.
thermometers Drugs for symptomatic
Adequate laboratory sample treatment.
medium and packaging Influenza vaccination
Disinfectants; hand hygiene Antibacterial hand wipes,
supplies alcohol-based hand sanitizer
gel and surface disinfectant
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Table 3. Specific health actions by shipping companies from April 20 through July 31 2009 in response to pandemic influen-
za A (H1N1) 2009
Actions of shipping companies All companies Cruise lines only
(N = 31) (%) (N = 3)
Implemented any new procedure to prevent or control influenza transmission 25 (81) 3
(e.g. companies’ travel policies, onboard measures, embarkation
and disembarkation procedures)
Instituted hygiene procedures at embarkation, disembarkation, or both 9 (29) 3
Added new vessel cleaning and disinfection procedures 9 (29) 3
Required staff to avoid deferrable travel to affected areas 7 (23) 1
Prohibited shore leave to crew 6 (19) 1
Added new health screening measures for crew and passengers 6 (19) 3
Prohibited crew from going to affected areas 3 (10) 0
Cancelled vessels’ journeys to certain ports 1 (3) 0
Withdrew provision orders for food consumption on board 1 (3) 0
tion, improved hand hygiene, reduction of hand shak-
ing, avoidance of crowding, cleaning of frequently
touched surfaces, health screening at embarkation,
monitoring and self monitoring for symptoms, wear-
ing of masks and gloves, isolation of ill persons, anti-
viral treatment, and chemoprophylaxis. All cruise ship
companies modified their existing outbreak control
plans due to lessons learned during the onset of the
pandemic.
MEASURES IMPOSED BY LOCAL HEALTH
AUTHORITIES
Approximately 32% (10/31) of companies experi-
enced one or more embarkation screening measures
imposed on their vessels by health authorities, i.e.
travellers’ health declarations 7/31 (23%), visual in-
spections for signs of illness 5/31 (16%), or tempera-
ture measurement 6/31 (19%). No company was re-
fused permission to enter a port because of pandemic
influenza A (H1N1) 2009, but 3 companies, includ-
ing 1 cruise line, were refused permission to embark
or disembark passengers or crew, and 2 were not
granted permission to discharge or load cargo or
stores subject to inspections by health authorities.
In two of the events, the delay of operations lasted
less than 3 hours; however, in one event, the author-
ities’ procedures resulted in a delay of more than 24
hours.
In the free text section the cruise ship companies
raised the concern that control guidelines issued by
port health authorities were not consistent between
countries and also inconsistent with the WHO guide-
lines. In companies managing cargo and other ships,
concerns were raised that customs’ requirements
hindered timely delivery of medication and personal
protective equipment to their ships in global ports.
Access to vaccination for sailors was not in the scope
of this survey because the vaccine was not available
before autumn 2009; however, in the free text sec-
tion two companies noted that health authorities in
most countries were not supportive in providing vac-
cinations to crew and passengers when it was avail-
able to groups at high risk and the general popula-
tion. In the authors´ experience (CS, BG) administra-
tive arrangements in many countries did not allow
companies to purchase the pandemic vaccine for
use on ships under non-national flags and in inter-
national waters.
CONCLUSIONS
Early in the pandemic influenza A (H1N1) 2009,
points of entry throughout the world became a fo-
cus of attention in the efforts to delay the cross-bor-
der spread of influenza. Our results show that both
the shipping industry and port health authorities like-
wise implemented infection control measures. All
cruise ship and many cargo ship companies initiat-
ed infection control measures or changed existing
procedures. Approximately one-fourth of all shipping
companies performed screening at embarkation, and
one-third experienced additional health screening
measures imposed by port health authorities.
Shipping companies raised the concern that
procedures by local port authorities were incon-
sistent between countries, as described before
concerning ship inspections in Europe [16, 17].
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Obstructed access to medical supplies, including
vaccination, was raised as an additional concern.
In our survey, no company was refused permis-
sion to enter a port because of pandemic influen-
za A (H1N1) 2009; however, 5 companies were
refused permission to embark or disembark trav-
ellers or cargo, which resulted in minor delays
for most and a delay of more than 24 hours for
1 cargo ship company.
Because of practical reasons, shipping company
management responded to the questionnaire, which
most likely resulted in an underestimation of events
and particular actions taken. In the perception of
four companies, outbreaks of Influenza A (H1N1)
were stopped by their efforts; however, we could not
measure this effect against predefined criteria. The
study population of “shipping companies” was gen-
erally ill defined. If compared to the world fleet of
ships of approximately 75,000, as estimated for the
year 2009 [15], the responding companies operated
1.3% of the global fleet of all ships and approximate-
ly 1.8% of all 53,000 ships registered to the IMO with
more than 500 gross tonnage. Twelve per cent of
CLIA members participated; however, we do not know
how many CLIA members were asked to participate
but declined. CLIA mainly represents North Ameri-
can companies and has a policy of having outbreak
control plans in place [18], which may explain the
rather uniform responses of the participating cruise
lines.
It is a unique feature of the shipping industry that
vessels must carry medically trained personnel, equip-
ment, and written protocols for medical care and
hygiene procedures. However, current protocols for
ships do not include pandemic influenza prepared-
ness, so companies had to implement additional pub-
lic health procedures. It would be beneficial to the
shipping industry and port health authorities if the
guidelines developed for preventing and controlling
pandemic influenza A (H1N1) 2009 on ships [11–
–13] were incorporated into future revisions of guid-
ance on medical care on board, such as the Inter-
national Medical Guide for Ships [10] and existing
outbreak control plans on cruise ships. These guide-
lines could also serve as a template for more generic
plans for preventing and controlling infectious dis-
eases on ships under observance of the legal require-
ments under the WHO International Health Regula-
tions 2005 [19]. Shipping companies must initiate or
continue comprehensive influenza pandemic plan-
ning to best be prepared for future events
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